Frias C, Cortés J, Seguí MA, Oyagüez I, Casado MA Cost-effectiveness analyses of docetaxel versus paclitaxel once weekly in patients with metastatic breast cancer in progression following anthracycline chemotherapy, in Spain Clin Transl Oncol. 2010;12(10):692-702 MÁS INFORMACIÓN